These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 37900123)

  • 1. Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids.
    Ni Y; Wang X; Wu Q; Yao Y; Xu Y; Li Y; Feng Q; Zhou M; Gou X
    Front Endocrinol (Lausanne); 2023; 14():1272214. PubMed ID: 37900123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of non-alcoholic steatohepatitis by Qushi Huayu decoction is associated with inhibition of the intestinal mitogen-activated protein kinase pathway.
    Leng J; Huang F; Hai Y; Tian H; Liu W; Fang Y; Hu Y; Peng J
    Phytomedicine; 2020 Jan; 66():153135. PubMed ID: 31790895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites.
    Zhu M; Wang X; Wang K; Zhao Z; Dang Y; Ji G; Li F; Zhou W
    Front Cell Infect Microbiol; 2023; 13():1066053. PubMed ID: 36779187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease.
    Feng Q; Liu W; Baker SS; Li H; Chen C; Liu Q; Tang S; Guan L; Tsompana M; Kozielski R; Baker RD; Peng J; Liu P; Zhu R; Hu Y; Zhu L
    Oncotarget; 2017 Apr; 8(17):27820-27838. PubMed ID: 28416740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition on XBP1s-driven lipogenesis by Qushi Huayu Decoction contributes to amelioration of hepatic steatosis induced by fructose.
    Tian H; Fang Y; Liu W; Wang J; Zhao J; Tang H; Yin Y; Hu Y; Peng J
    J Ethnopharmacol; 2023 Jan; 301():115806. PubMed ID: 36216198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease.
    Tang W; Yao X; Xia F; Yang M; Chen Z; Zhou B; Liu Q
    Oxid Med Cell Longev; 2018; 2018():7261619. PubMed ID: 30671174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
    Shen SH; Zhong TY; Peng C; Fang J; Lv B
    BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qushi Huayu decoction attenuated hepatic lipid accumulation via JAK2/STAT3/CPT-1A-related fatty acid β-oxidation in mice with non-alcoholic steatohepatitis.
    Sun Q; Wang X; Xin X; An Z; Hu Y; Feng Q
    Pharm Biol; 2022 Dec; 60(1):2124-2133. PubMed ID: 36308318
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Tian G; Wang W; Xia E; Chen W; Zhang S
    Front Cell Infect Microbiol; 2023; 13():1078447. PubMed ID: 36860985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geniposide and Chlorogenic Acid Combination Ameliorates Non-alcoholic Steatohepatitis Involving the Protection on the Gut Barrier Function in Mouse Induced by High-Fat Diet.
    Peng JH; Leng J; Tian HJ; Yang T; Fang Y; Feng Q; Zhao Y; Hu YY
    Front Pharmacol; 2018; 9():1399. PubMed ID: 30618733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression.
    Zhou Y; Zheng T; Chen H; Li Y; Huang H; Chen W; Du Y; He J; Li Y; Cao J; Nie Y; Zhou Y
    Cell Physiol Biochem; 2018; 51(5):2123-2135. PubMed ID: 30522122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology.
    Gao SS; Sun JJ; Wang X; Hu YY; Feng Q; Gou XJ
    Biomed Res Int; 2020; 2020():1704960. PubMed ID: 33204683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Metabolomic Study on the Intervention of Traditional Chinese Medicine Qushi Huayu Decoction on Rat Model of Fatty Liver Induced by High-Fat Diet.
    Gou XJ; Gao S; Chen L; Feng Q; Hu YY
    Biomed Res Int; 2019; 2019():5920485. PubMed ID: 30881991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of Qushi Huayu Decoction on cathepsin B and tumor necrosis factor-alpha expression in rats with non-alcoholic steatohepatitis].
    Zhang H; Feng Q; Li HS; Chen SD; Wang XN; Peng JH; Zhang N; Hu YY
    Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):928-33. PubMed ID: 18782536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tectorigenin ameliorated high-fat diet-induced nonalcoholic fatty liver disease through anti-inflammation and modulating gut microbiota in mice.
    Duan R; Huang K; Guan X; Li S; Xia J; Shen M; Sun Z; Yu Z
    Food Chem Toxicol; 2022 Jun; 164():112948. PubMed ID: 35390440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated omics analysis unraveled the microbiome-mediated effects of Yijin-Tang on hepatosteatosis and insulin resistance in obese mouse.
    Lee JE; Lee SM; Jung J
    Phytomedicine; 2020 Dec; 79():153354. PubMed ID: 32992082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses.
    Wang S; Li X; Zhang B; Li Y; Chen K; Qi H; Gao M; Rong J; Liu L; Wan Y; Dong X; Yan M; Ma L; Li P; Zhao T
    Biomed Pharmacother; 2024 Apr; 173():116405. PubMed ID: 38484559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
    Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
    Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erchen Decoction alleviates obesity-related hepatic steatosis via modulating gut microbiota-drived butyric acid contents and promoting fatty acid β-oxidation.
    Zhang L; Chen N; Zhan L; Bi T; Zhou W; Zhang L; Zhu L
    J Ethnopharmacol; 2023 Dec; 317():116811. PubMed ID: 37336336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZeXie decoction alleviates non-alcoholic fatty liver disease in rats: the study of genes, lipids, and gut microbiotas.
    Zhang F; Wu J; Ruan H; Xia J; Xue H; Wang J; Li Q; Shi Y
    Biochem Biophys Res Commun; 2022 Dec; 632():129-138. PubMed ID: 36209581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.